- Home
- AQB vs IMCC Comparison
AQB vs IMCC Comparison
Compare AQB & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQB | IMCC |
|---|---|---|
| Founded | 1991 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 4.1M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AQB | IMCC |
|---|---|---|
| Price | $0.93 | $0.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.9K | ★ 85.3K |
| Earning Date | 03-06-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,472,659.00 | N/A |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.57 | $0.54 |
| 52 Week High | $2.95 | $7.12 |
Technical Indicators
Market Signals| Indicator | AQB | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 33.32 |
| Support Level | $0.86 | $0.54 |
| Resistance Level | $0.97 | $1.05 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 46.42 | 10.03 |
Price Performance
Historical ComparisonAbout AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.